electroCore (ECOR) Stock Analysis

What electroCore does

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Key metrics

ETFs linked to ECOR

Broad-market and Healthcare sector ETFs an investor holding electroCore is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ECOR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for electroCore?

electroCore trades under the ticker ECOR on NASDAQ.

Which exchange is ECOR listed on?

ECOR is listed on NASDAQ.

What sector does electroCore operate in?

electroCore is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze ECOR in a portfolio?

PortView shows ECOR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.